In the News

Get the Flash Player to see this player.

Dermalastyl Times Square

Home | About Us | Elastatropin® | News | Links | Contact

News

Renowned anti-aging doctor initiates major study of DermaLastyl; measuring wrinkles before/after

New York, N.Y. – March 7, 2007 – Matrix Design, Inc./DermaPlus, Inc. announces Dr. Steven Lamm, renowned anti-aging doctor, has initiated a major clinical study of DermaLastyl-Bx Pro/Face skin care cream. Dr. Lamm has engaged 34 subjects to participate in a 12 week profilometry study while using the DermaLastyl wrinkle cream. Each subject’s face wrinkles are measured at the onset, measured again in 6 weeks, and then at 12 weeks.

“We are going to actually calculate the exact reduction in facial wrinkles as they use DermaLastyl-Bx Pro/Face. This profilometry study includes 34 subjects who will use the cream for three months. We will closely monitor them measuring their wrinkles at intervals to test if DermaLastyl replenishes sufficient elastin to significantly slow the onset of wrinkles and facial sagging as claimed. The initial phase Skin Tolerance Study of DermaLastyl that we conducted last year found 96 percent of my study subjects had positive results experiencing a more youthful appearance after six weeks. Now we are going to actually calculate the exact reduction in wrinkles over 12 weeks,” states Dr. Lamm.

Dr. Steven Lamm is an author of several books on health and aging and is known as the 'house doctor' on ABC's "The View”. An internist, he is an Assistant Professor of Medicine at New York University School of Medicine and maintains a private practice in New York City.

About Matrix Design/DermaPlus
Matrix Design, Inc./DermaPlus, Inc. is a biotechnology company that designs and manufactures sophisticated, high performance biomaterials such as Tropoelastin-based Elastatropin for use in the cosmeceutical and personal care products. Based on human genetic sequences, these biomaterials can be customized to reflect the genetic makeup of human tissues, population groups or even single individuals. DermaLastyl-B, DermaLastyl-E, DermaLastyl-Bx Pro/Face, and DermaLastyl-Ex are the first genetically engineered products on the market that help restore elastin and elastic properties to the skin and around the eyes. Used properly, DermaLastyl could postpone the need for Botox or cosmetic surgery and possibly extends the life of previous cosmetic procedures. Keracyte-b is designed to stimulate and re-vitalize hair follicles so as to allow existing hair shafts to grow thicker and stronger.

Available only at DermaLastyl.com, DermaLastylPro.com, or Keracyte.com and 800-335-8312

Contact:
Jerry Jennings
Emerson Gerard Associates
561-881-7318
mediareply@egaplus.com

More News

© 2008 Protein Genomics, Inc. All Rights Reserved.